Open source drug discovery– A new paradigm of collaborative research in tuberculosis drug development-Reference-Cited by-同舟云学术

Open source drug discovery– A new paradigm of collaborative research in tuberculosis drug development

Published:2011-07 Issue: Volume: Page:
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Bhardwaj Anshu,Scaria Vinod,Raghava Gajendra Pal Singh,Lynn Andrew Michael,Chandra Nagasuma,Banerjee Sulagna,Raghunandanan Muthukurussi V.,Pandey Vikas,Taneja Bhupesh,Yadav Jyoti,Dash Debasis,Bhattacharya Jaijit,Misra Amit,Kumar Anil,Ramachandran Srinivasan,Thomas Zakir,Brahmachari Samir K.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference27 articles.

1. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis;Sacchettini;Nat Rev Microbiol,2008

2. Multidrug-resistant and extensively drug-resistant tuberculosis: a review;Chan;Curr Opin Infect Dis,2008

3. Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs;Budha;Curr Med Chem,2008

4. New approaches to filling the gap in tuberculosis drug discovery;Casenghi;PLoS Med,2007

5. Spicy IP,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): an open-source disease-specific drug discovery portal;Gigabyte;2024-03-14

2. Characterizing emerging companies in computational drug development;Nature Computational Science;2024-02-26

3. Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis;Pharmaceuticals;2023-12-22

4. Critical success factors for open source innovation in pharma industry: learning from two case studies;The TQM Journal;2022-09-28

5. Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries;The Journal of Technology Transfer;2022-08-18